1. Home
  2. KLTR vs TLSA Comparison

KLTR vs TLSA Comparison

Compare KLTR & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

KLTR

Kaltura Inc.

N/A

Current Price

$1.39

Market Cap

191.6M

Sector

Technology

ML Signal

N/A

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

N/A

Current Price

$1.46

Market Cap

192.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KLTR
TLSA
Founded
2006
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
191.6M
192.1M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
KLTR
TLSA
Price
$1.39
$1.46
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$3.50
N/A
AVG Volume (30 Days)
300.6K
131.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.07
N/A
Revenue
$178,717,000.00
N/A
Revenue This Year
$3.10
N/A
Revenue Next Year
$1.08
N/A
P/E Ratio
$19.50
N/A
Revenue Growth
2.02
N/A
52 Week Low
$1.21
$0.73
52 Week High
$2.29
$2.60

Technical Indicators

Market Signals
Indicator
KLTR
TLSA
Relative Strength Index (RSI) 43.14 48.06
Support Level N/A $1.29
Resistance Level $1.68 $1.65
Average True Range (ATR) 0.08 0.09
MACD -0.00 0.01
Stochastic Oscillator 41.94 68.57

Price Performance

Historical Comparison
KLTR
TLSA

About KLTR Kaltura Inc.

Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

Share on Social Networks: